Sars-cov-2 Related Interstitial Pneumonia

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2020-04-02
Clinical Trial Update: TOFAcitinib in SARS-CoV2 Pneumonia [Phase 2]
Phase 2 trial update for tofacitinib in SARS-CoV-2 related interstitial pneumonia.